Artificial Intelligence could Help Tackle Coronary Heart Disease

Scientist from King’s College London believe that Artificial Intelligence could hold the key to identifying the best way to treat the country’s biggest killer, coronary heart disease (CHD). And now the team has secured close to £250,000 from by national charity Heart Research UK to pursue the test, that if successful would be less invasive, faster and more cost-effective than existing procedures.

Lead scientist Dr Jack Lee and his King’s College London team have been awarded a Novel and Emerging Technologies (NET) Grant by Heart Research UK to develop a type of advanced computing technique which will learn to identify patterns from blood flow simulations in thousands of coronary arteries.

Called 'deep learning', the computing algorithm will make a pressure-based assessment of coronary artery narrowings safer, quicker and easier than at present

When a patient is admitted to a catheter lab for treatment for CHD, doctors must decide whether the artery should be reopened physically with a stent or, in less severe cases, treated with medication.

There is much evidence that measuring the pressure drop across the coronary artery narrowing is a highly accurate way of deciding the best treatment. The test involves inserting a wire into the coronary artery which has a sensor to measure pressure.

However, the majority of catheter labs in the UK do not currently measure pressure routinely due to the risk to patients, and the extra time and cost of the procedure.

Coronary angiography is the conventional method for looking at the coronary arteries and involves taking x-ray images of the blood vessels. This information can be combined with a computer model of blood flow to estimate the pressure drop, without carrying out invasive measurements on patients. There are already accurate methods to simulate the blood flow through blood vessels but they are time-consuming and require special training to perform.

In an alternative approach, Dr Lee's project will use an advanced computing algorithm known as 'deep learning'. This is a type of artificial intelligence technique which will identify patterns from blood flow simulations in thousands of coronary arteries, so the computer ‘learns’ how the geometry of the narrowings affects the pressure pattern.

In turn, this information may allow the pressure drop across the coronary artery narrowing to be calculated directly and in real-time from the angiography images. The team will then test the new method on real patient data to demonstrate its clinical usefulness.

Dr Lee said: "The successful outcome of this research may help doctors decide on the best treatment for CHD using a test with reduced risk and less discomfort for patients. A fast and automatic method may also lead to shorter waiting times and cost savings for the NHS."

Barbara Harpham, Chief Executive at Heart Research UK, said: "CHD, where the coronary arteries that supply the heart muscle with blood become narrowed by a gradual build-up of fatty material, is the leading cause of death in the UK.

"This exciting project at King’s College London will use the most advanced computing methods to develop a new test with the aim of benefiting patients with CHD as soon as possible. We look forward to supporting Dr Lee and his team and seeing the results of this pioneering medical research."

Heart Research UK's NET Grants are for research projects which focus on the development of new and innovative technologies to diagnose, treat and prevent heart disease and related conditions. They have given out NET Grants since 2006, awarding £2,657,041 in total.

Most Popular Now

App Determines COVID-19 Disease Severity…

A new mobile app can help clinicians determine which patients with the novel coronavirus (COVID-19) are likely to have severe cases. Created by researchers at NYU College of Dentistry, the...

NHS Trust Revolutionises Access to Menta…

North Staffordshire Combined Healthcare NHS Trust has selected the DXC Open Health Connect platform from DXC Technology (NYSE: DXC) and is creating a blueprint that could dramatically reduce mental health...

FDA Permits Marketing of First Game-Base…

The U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital therapeutic device to improve attention function in children with attention deficit hyperactivity disorder (ADHD). The prescription-only...

HealthTunes Launches iOS App to Deliver …

HealthTunes has announceed the launch of the iOS App specifically created to help alleviate the mental health suffering of frontline healthcare workers. After months of fighting the pandemic, many frontline...

Philips Announces Collaboration with Ame…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has once again joined forces with the American Telemedicine Association (ATA) to help further the...

Bluetooth Technology, the Best Ally to D…

"Tracers have been and are essential to manage the pandemic. Today, the tracing is done by hand and this work is slow and inaccurate. However, as we have seen, technology...

Successful Debut for DMEA sparks

16 - 18 June 2020, Berlin, Germany. DMEA sparks opened, featuring a wide range of topics. Federal Minister of Health Jens Spahn kicked off events. In his interview he focused on...

Digital Mental Health support to be Prov…

SilverCloud, the leading digital therapeutics provider, has partnered with mental health charity Northpoint Wellbeing to co-develop a new digital therapy programme to alleviate anxiety in young people. Coming at a...

Siemens Healthineers Offers Flexible Tel…

With its teamplay myCare Companion software, the company is bringing a new and flexible telemedicine solution to the market that enables remote care for patients with chronic diseases. The teamplay...

Siemens Healthineers Uses Artificial Int…

Siemens Healthineers introduces Ysio X.pree(1), the world's first intelligent X-ray system with integrated AI for optimizing the daily routine of image acquisition in radiography. To assist radiologists with the subsequent...

Computer Modelling Predicts where Vaccin…

Researchers have developed a model that can estimate regional disease burden and the impact of vaccination, even in the absence of robust surveillance data, a study in eLife reveals. The report...

Andrea Fiumicelli Appointed as a CEO of …

Dedalus Group, leader in Europe and one of the world's leading players in clinical and healthcare information systems supporting clinical professionals and healthcare facilities thanks to a wide portfolio of...